Bristol-Myers Squibb Company
NYSE: BMY
$39.66
+$0.20 (+0.5%)
Closing Price on July 5, 2024
BMY Articles
The last trading day before the Christmas holiday has stocks headed for a mixed opening following a good, not great, inflation report.
Published:
While many investment professionals suggest short Treasury paper and money markets, healthcare is the place in 2024 for long-term investors looking for growth and income. Demand is growing as the...
Published:
2023 has been a much better year than 2022, as all major indices are higher. The tech-heavy Nasdaq is up a whopping 32.5%, while the venerable S&P 500 is up 15.36% and the Dow Jones Industrial just...
Published:
Private equity firms and institutions have been buying up top health care stocks like these seven for their strong total return potential and a degree of safety in what soon could be some very rough...
Published:
These are the top analyst upgrades, downgrades, and initiations seen before markets opened on Tuesday, July 11, 2023.
Published:
Thursday's top analyst upgrades and downgrades included Amazon.com, Bristol-Myers Squibb, Coherent, Deere, GoDaddy, Pinterest, Rexford Industrial Realty, Salesforce, Uber Technologies, Vale,...
Published:
For some investors, buying long-dated call options on blue chip stocks that have lagged the market makes sense now. These five outstanding Goldman Sachs stock picks fit the bill and look very...
Published:
These four companies, including one Dow Jones industrial, are set to report quarterly earnings early Thursday.
Published:
Here is a look at what to expect when these three companies report quarterly results before markets open on Wednesday.
Published:
Monday's additional top analyst upgrades and downgrades were on Bristol Myers Squibb, Ford, Fortinet, General Motors, Kraft Heinz, Kroger, Merck, Procter & Gamble, Toast and more.
Published:
Tuesday's top analyst upgrades and downgrades included Bristol-Myers Squibb, Costco Wholesale, Dollar General, Exxon Mobil, FedEx, Horizon Therapeutics, Hyatt Hotels, Lucid, Medtronic, Micron...
Published:
Wednesday's additional top analyst upgrades and downgrades were on Block, Bristol-Myers Squibb, Clorox, CSX, Kimberly-Clark, Merck, Match, Target and more.
Published:
The bear market rally that started in June is over and it is clearly a time to move to safer dividend stocks. These eight outstanding health care stocks make sense for worried investors now as they...
Published:
Monday's top analyst upgrades and downgrades included Bristol-Myers Squibb, Cheniere Energy, Chewy, Costco Wholesale, CrowdStrike, Exact Sciences, Lululemon Athletica, New York Community Bancorp,...
Published:
Here are previews of three pharmaceutical giants set to report earnings before markets open on Friday.
Published: